Search alternatives:
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
point increase » unit increase (Expand Search)
main decrease » gain decreased (Expand Search), mean decrease (Expand Search), point decrease (Expand Search)
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
point increase » unit increase (Expand Search)
main decrease » gain decreased (Expand Search), mean decrease (Expand Search), point decrease (Expand Search)
-
18841
Table 5_Microbiota–sphingolipid pathway in generalized epilepsy: evidence from Mendelian randomization and clinical metabolomics.xlsx
Published 2025“…In contrast, Gamma-proteobacteria and Oxalobacter demonstrated bidirectional mediation: via glutamine conjugate of C<sub>6</sub>H<sub>10</sub>O<sub>2</sub>(2) and cerotoylcarnitine (C<sub>26</sub>) (P = 0.026 and P = 0.033, respectively); while these pathways were protective in mediation, higher abundances were associated with increased risk of generalized epilepsy. Notably, no significant mediators were identified for epilepsy or focal epilepsy. …”
-
18842
Table 1_Emerging cardiovascular toxicity associated with CDK4/6 inhibitors: real-world insights from the FDA adverse event reporting system.xlsx
Published 2025“…Disproportionality analysis revealed that Abemaciclib was significantly increased signal of venous thromboembolism (ROR = 2.57 [2.24-2.96]), whereas cardiac arrhythmia (ROR = 2.51 [2.13-2.96]) and torsade de pointes/QT prolongation (ROR = 5.7 [5-6.5]) were showed significantly disproportionate for ribociclib. …”
-
18843
Table 4_Emerging cardiovascular toxicity associated with CDK4/6 inhibitors: real-world insights from the FDA adverse event reporting system.xlsx
Published 2025“…Disproportionality analysis revealed that Abemaciclib was significantly increased signal of venous thromboembolism (ROR = 2.57 [2.24-2.96]), whereas cardiac arrhythmia (ROR = 2.51 [2.13-2.96]) and torsade de pointes/QT prolongation (ROR = 5.7 [5-6.5]) were showed significantly disproportionate for ribociclib. …”
-
18844
Table 3_Microbiota–sphingolipid pathway in generalized epilepsy: evidence from Mendelian randomization and clinical metabolomics.xlsx
Published 2025“…In contrast, Gamma-proteobacteria and Oxalobacter demonstrated bidirectional mediation: via glutamine conjugate of C<sub>6</sub>H<sub>10</sub>O<sub>2</sub>(2) and cerotoylcarnitine (C<sub>26</sub>) (P = 0.026 and P = 0.033, respectively); while these pathways were protective in mediation, higher abundances were associated with increased risk of generalized epilepsy. Notably, no significant mediators were identified for epilepsy or focal epilepsy. …”
-
18845
Table 1_Microbiota–sphingolipid pathway in generalized epilepsy: evidence from Mendelian randomization and clinical metabolomics.xlsx
Published 2025“…In contrast, Gamma-proteobacteria and Oxalobacter demonstrated bidirectional mediation: via glutamine conjugate of C<sub>6</sub>H<sub>10</sub>O<sub>2</sub>(2) and cerotoylcarnitine (C<sub>26</sub>) (P = 0.026 and P = 0.033, respectively); while these pathways were protective in mediation, higher abundances were associated with increased risk of generalized epilepsy. Notably, no significant mediators were identified for epilepsy or focal epilepsy. …”
-
18846
Table 3_Emerging cardiovascular toxicity associated with CDK4/6 inhibitors: real-world insights from the FDA adverse event reporting system.xlsx
Published 2025“…Disproportionality analysis revealed that Abemaciclib was significantly increased signal of venous thromboembolism (ROR = 2.57 [2.24-2.96]), whereas cardiac arrhythmia (ROR = 2.51 [2.13-2.96]) and torsade de pointes/QT prolongation (ROR = 5.7 [5-6.5]) were showed significantly disproportionate for ribociclib. …”
-
18847
Table 2_Microbiota–sphingolipid pathway in generalized epilepsy: evidence from Mendelian randomization and clinical metabolomics.xlsx
Published 2025“…In contrast, Gamma-proteobacteria and Oxalobacter demonstrated bidirectional mediation: via glutamine conjugate of C<sub>6</sub>H<sub>10</sub>O<sub>2</sub>(2) and cerotoylcarnitine (C<sub>26</sub>) (P = 0.026 and P = 0.033, respectively); while these pathways were protective in mediation, higher abundances were associated with increased risk of generalized epilepsy. Notably, no significant mediators were identified for epilepsy or focal epilepsy. …”
-
18848
Table 1_Impact of individualized tidal volume strategies on intraoperative lung protection and inflammatory markers in laparoscopic cholecystectomy: a randomized controlled trial.d...
Published 2025“…However, the increases in these inflammatory markers were significantly greater in Group C than in Group T (p < 0.05). …”
-
18849
Data Sheet 1_Level of discharge readiness and influencing factors in ischaemic stroke patients: a descriptive, cross-sectional study.doc
Published 2025“…Statistical analyses were performed using SPSS 26.0, with significant results visualised in GraphPad Prism 9.0. …”
-
18850
Table 6_Microbiota–sphingolipid pathway in generalized epilepsy: evidence from Mendelian randomization and clinical metabolomics.xlsx
Published 2025“…In contrast, Gamma-proteobacteria and Oxalobacter demonstrated bidirectional mediation: via glutamine conjugate of C<sub>6</sub>H<sub>10</sub>O<sub>2</sub>(2) and cerotoylcarnitine (C<sub>26</sub>) (P = 0.026 and P = 0.033, respectively); while these pathways were protective in mediation, higher abundances were associated with increased risk of generalized epilepsy. Notably, no significant mediators were identified for epilepsy or focal epilepsy. …”
-
18851
Table 4_Microbiota–sphingolipid pathway in generalized epilepsy: evidence from Mendelian randomization and clinical metabolomics.xlsx
Published 2025“…In contrast, Gamma-proteobacteria and Oxalobacter demonstrated bidirectional mediation: via glutamine conjugate of C<sub>6</sub>H<sub>10</sub>O<sub>2</sub>(2) and cerotoylcarnitine (C<sub>26</sub>) (P = 0.026 and P = 0.033, respectively); while these pathways were protective in mediation, higher abundances were associated with increased risk of generalized epilepsy. Notably, no significant mediators were identified for epilepsy or focal epilepsy. …”
-
18852
Data Sheet 1_Disproportionality analysis of adverse events associated with pacritinib: a real-world study based on FDA Adverse Event Reporting System (FAERS) database.docx
Published 2025“…Common preferred terms were identified, including diarrhea, fatigue, death, nausea, platelet count decreased, and hemoglobin decreased. Notably, 26 off-label AEs were also identified.…”
-
18853
Opportunistic analysis of clinically actionable DPYD gene variants in a germline testing cohort in India
Published 2025“…</p> <p>A total of 95 individuals (5.3%) carried at least one decreased or no function DPYD variant, indicating a significant prevalence of clinically actionable genotypes in this Indian cohort. …”
-
18854
Data Sheet 1_Peers are as persuasive as experts in reducing willingness to pay for sugary foods.pdf
Published 2025“…</p>Results<p>All audio interventions significantly decreased participants’ WTP for sugar-containing products compared to sugar-free products. …”
-
18855
<b>Keystone taxa and microbial network complexity, rather than diversity, sustain soil multifunctionality along an elevational gradient in a subtropical karst mountain</b>
Published 2025“…Notably, the positive effects of network complexity and keystone taxa abundance on soil EMF decreased with increasing threshold levels of EMF, yet keystone taxa abundance retained a significant positive effect even at the highest threshold (75%). …”
-
18856
Supplementary Material for: Status of inpatients with pediatric epilepsy in children’s hospitals in China (2016–2021)
Published 2024“…The root-mean-square-error between the Inter-Provincial Visits Indexes decreased from 1.70 to 0.90, decreasing significantly (R2=0.8306). …”
-
18857
DMSO reduction in response to high irradiance exposure from simulated vertical mixing.
Published 2025“…Significance is determined by two-tailed Student’s t-tests (*: p < 0.05, **: p < 0.01, n.s.: non-significant). …”
-
18858
Image 3_CS Ratio is an immune-related prognostic biomarker for cervical cancer.tiff
Published 2025“…The CS Ratio significantly decreased with advancing FIGO stage (P < 0.05). …”
-
18859
Image 2_CS Ratio is an immune-related prognostic biomarker for cervical cancer.tiff
Published 2025“…The CS Ratio significantly decreased with advancing FIGO stage (P < 0.05). …”
-
18860
Image 1_CS Ratio is an immune-related prognostic biomarker for cervical cancer.tiff
Published 2025“…The CS Ratio significantly decreased with advancing FIGO stage (P < 0.05). …”